Maple Leaf Foods Reports Second Quarter 2024 Financial Results

TSX: MFI
www.mapleleaffoods.com

Investor Contact
[email protected]
Media Contact
[email protected]  

Maple Leaf records year-over-year Adjusted EBITDA growth of 37% to $141 million

Company on track to meet its 2024 priorities and execute its transformative spin-off of pork business

MISSISSAUGA, ON, Aug. 8, 2024 /CNW/ - Maple Leaf Foods Inc. ("Maple Leaf Foods" or "the Company") (TSX: MFI) today reported its financial results for the second quarter ended June 30, 2024.

"In the second quarter of 2024, we made excellent progress in executing our strategic playbook, delivering Adjusted EBITDA of $141 million, 37% growth over the second quarter of last year, and 11.2% Adjusted EBITDA Margin, a 310 basis point improvement year over year," said Curtis Frank, President and CEO of Maple Leaf Foods. "Several key elements contributed to our performance, including 3.2% year-over-year sales growth in our prepared meats business, improved pork market conditions, growth in our sustainable meats portfolio, better overall sales mix, and contributions from our large capital projects."

"We remain laser-focused on executing our priorities for 2024, and we are not taking our eye off the longer-term goals we have set for ourselves" continued Mr. Frank. "We are harvesting the benefits from our London poultry plant and Bacon Centre of Excellence, driving cost out of the business, deleveraging our balance sheet, and drawing on our team's proven ability to demonstrate agility in a challenging consumer demand environment."

"Looking ahead, we are on a clear path to unleashing the potential of our business by separating into two independent public companies, each primed for growth and positioned to be a leader in its field," stated Mr. Frank. "I am confident, that these two companies - Maple Leaf Foods and the new Pork Company - will unlock the value of their respective organizations for the benefit of all stakeholders, with dedicated management teams and the financial independence to pursue their own value creation strategies. This will be the next exciting milestone step in executing the Maple Leaf playbook." 

Second Quarter 2024 Highlights

• Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA")⁽ⁱ⁾ grew to $141 million, a 37% increase from the second quarter of last year, with Adjusted EBITDA margin increasing from 8.1% to 11.2% for the same period.
• Sales were $1,261 million for the second quarter, compared to $1,266 million for the same period last year. Sales in Prepared Foods increased approximately 1%. Within Prepared Foods, prepared meats increased 3.2% which was partially offset by declines in poultry and plant protein of 3.9% and 2.5% respectively, compared to the same period in the prior year. Sales in the Pork operating unit decreased by 4.2% compared to last year.
• Loss for the second quarter of 2024 was $26 million ($0.21 per basic share) compared to a loss of $54 million ($0.44 loss per basic share) last year.
• Capital expenditures in the second quarter of 2024 were $16 million compared to $53 million in the second quarter last year, consistent with the Company's focus of disciplined capital management, and reflecting the completion of its large capital projects.
• Net Debt⁽ⁱ⁾ was $1,723 million, with Net Debt to trailing four quarters Adjusted EBITDA of 3.4x, an improvement from 3.7x at the end of the first quarter.
• Free cash flow⁽ⁱ⁾ improved to $27 million, an increase of $103 million from the same quarter last year.

Unlocking Value through the Creation of Two Independent Public Companies

• On July 9, 2024, Maple Leaf Foods announced plans to separate into two independent public companies through the spin-off of its pork business. The Company expects that this transaction will be completed in 2025. An update to the previously provided management's preliminary estimates of the relative size of the two companies reflecting the last twelve months ended June 30, 2024 can be found in the section titled Management's Estimates on the Pork business spin-off, and related Non-IFRS measures, in this news release.

Outlook

• For the full year 2024, the Company expects:
  • Low single-digit revenue growth
  • Adjusted EBITDA margin expansion over 2023
  • To generate increased free cash flow and delever the balance sheet
  • Total capital expenditures this year are expected to be in the range of $120 - $140 million, largely focused on maintenance capital and optimization of its existing network

^(i)	Refer to the section titled Non-IFRS Financial Measures in this news release.

Financial Highlights

	As at or for the							As at or for the
Measure^(i) (Unaudited)	Three months ended June 30,							Six months ended June 30,
		2024		2023		Change		2024		2023		Change
Sales^(ii)		$   1,260.9		$   1,265.8		(0.4) %		$  2,414.1		$  2,436.9		(0.9) %
(Loss) Earnings		$       (26.2)		$       (53.7)		51.2 %		$       25.4		$    (111.4)		nm^(iv)
Basic (Loss) Earnings per Share		$       (0.21)		$       (0.44)		52.3 %		$       0.21		$     (0.92)		nm^(iv)
Adjusted Operating Earnings^(iii)		$        78.1		$        45.9		70.3 %		$     131.1		$      65.2		101.1 %
Adjusted Earnings (Loss) per Share^(iii)		$        0.18		$        0.00		nm^(iv)		$       0.22		$     (0.12)		nm^(iv)
Adjusted EBITDA^(iii)		$      140.9		$      103.1		36.7 %		$     257.3		$    178.4		44.2 %
Adjusted EBT^(iii)		$        34.4		$          6.7		413.4 %		$       44.8		$       (7.3)		nm^(iv)
Free Cash Flow^(iii)		$        27.0		$       (76.3)		nm^(iv)		$     100.7		$     (64.0)		nm^(iv)
Net Debt^(iii)								$ (1,723.1)		$(1,807.4)		4.7 %

^(i)	All financial measures in millions of dollars except Basic and Adjusted Earnings per Share.
^(ii)	Quarterly amounts for 2023 have been adjusted to eliminate new sales agreements entered into during the year that contained an expectation of repurchase, which had previously been reported as external sales.
^(iii)	Refer to the section titled Non-IFRS Financial Measures in this news release.
^(iv)	Not meaningful.

Sales for the second quarter of 2024 were $1,260.9 million compared to $1,265.8 million last year, a decrease of 0.4%. Sales in the Prepared Foods operating unit increased 1.0%. Within Prepared Foods, prepared meats sales increased 3.2% which was partially offset by declines in poultry and plant protein of 3.9% and 2.5% respectively, compared to the same period in the prior year. Sales in the Pork operating unit decreased by 4.2% compared to the same period in the prior year.

Year-to-date sales for 2024 were $2,414.1 million compared to $2,436.9 million last year, a decrease of 0.9%. Prepared Foods sales increased marginally by 0.4%, with an increase in prepared meats sales of 3.0% largely offset by declines in poultry and plant protein of 5.5% and 4.1%, respectively. Pork operating unit sales declined 4.4% compared to the prior year period.

As a result of improvements in pork markets, reduction of start-up expenses at new facilities, and improvement in operational efficiencies, all of which were partially offset by increased Selling, General and Administrative expenses ("SG&A"), unrealized mark to market valuation of biological assets and derivatives, and higher interest expense, Loss for the second quarter of 2024 of $26.2 million ($0.21 loss per basic share) improved compared to a loss of $53.7 million ($0.44 loss per basic share) last year.

Year-to-date earnings for 2024 were $25.4 million ($0.21 earnings per basic share) compared to a loss of $111.4 million ($0.92 loss per basic share) last year. The increase was driven by improvement in pork markets, reduction of start-up expenses at new facilities, and improvements in operational efficiencies, unrealized mark to market valuation of biological assets and derivatives that are reported outside of adjusted operating earnings, and lower restructuring charges. All partly offset by higher SG&A, interest expense, and income taxes.

Adjusted Operating Earnings for the second quarter of 2024 were $78.1 million compared to $45.9 million last year, and Adjusted Earnings per Share for the second quarter of 2024 was $0.18 compared to $0.00 last year. The increase was a result of improved pork market conditions and operational efficiencies, partly offset by higher SG&A.

Year-to-date Adjusted Operating Earnings for 2024 were $131.1 million compared to $65.2 million last year, and Adjusted Earnings per Share for 2024 was $0.22 compared to loss of $0.12 last year due to similar factors as noted for the second quarter above.

Adjusted Earnings Before Taxes ("Adjusted EBT") for the second quarter of 2024 were $34.4 million compared to $6.7 million last year. Adjusted EBT was driven by improved pork market conditions and operating efficiencies partly offset by interest expense due to higher interest rates, and higher SG&A.

Year-to-date Adjusted EBT for 2024 were $44.8 million compared to loss of $7.3 million last year due to similar factors as noted above.

Free Cash Flow for the second quarter of 2024 was $27.0 million compared to Free Cash Flow of negative $76.3 million in the prior year. The improvement was driven by improved earnings after the removal of non-cash items, income tax refunds, lower restructuring payments, and reduced investment in working capital, combined with lower spending on maintenance capital.

Year-to-date Free Cash Flow for 2024 was $100.7 million compared to Free Cash Flow of negative $64.0 million in the prior year. Free Cash Flow was up significantly due to the factors mentioned above for the second quarter.

Net Debt as at June 30, 2024 was $1,723.1 million, a decrease of $84.3 million compared to the prior year.

For further discussion on key operational metrics and results refer to the section titled Operating Review.

Note: Several items are excluded from the discussions of underlying earnings performance as they are not representative of ongoing operational activities. Refer to the section entitled Non-IFRS Financial Measures at the end of this news release for a description and reconciliation of all non-IFRS financial measures. 

Operating Review

During the first quarter of 2024, the Company announced an update to its strategic blueprint (the "Blueprint") that reflects the progress it has made toward achieving its Purpose and Vision and establishes the roadmap for the next chapter for how Maple Leaf Foods intends to deliver on these objectives.

As part of delivering on these objectives, the Company combined its Meat and Plant protein businesses and aligned its organizational structure to focus on growth potential in key markets and drive operational efficiencies. As a result in the first quarter of 2024, Maple Leaf Foods began to report its business and operational results as a consolidated protein company, and updated its Adjusted EBITDA margin target of 14% - 16% to include Plant protein. 

As a consolidated protein company, Maple Leaf Foods has two operating units: Prepared Foods and Pork, which represent on average approximately 75% and 25% of total Company revenue respectively. Prepared Foods combines the operations of prepared meats, plant protein, and poultry, which represent on average approximately 50%, 5% and 20% of total Company revenue respectively.

The following table summarizes the Company's sales, gross profit, SG&A, Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted EBT for the three and six months ended June 30, 2024 and June 30, 2023.

	Three months ended June 30,				Six months ended June 30,
($ millions except where noted otherwise) (Unaudited)		2024		2023		2024		2023
Sales^(i)		$       1,260.9		$       1,265.8		$       2,414.1		$      2,436.9
Gross profit (loss)		$          131.2		$            93.6		$          357.5		$         170.0
Selling, general and administrative expenses		$          116.6		$          106.2		$          226.7		$         208.9
Adjusted Operating Earnings^(ii)		$            78.1		$            45.9		$          131.1		$           65.2
Adjusted EBITDA^(ii)		$          140.9		$          103.1		$          257.3		$         178.4
Adjusted EBITDA Margin^(i)(ii)		11.2 %		8.1 %		10.7 %		7.3 %
Adjusted EBT^(i)		$            34.4		$              6.7		$            44.8		$            (7.3)

^(i)	Quarterly amounts for 2023 have been adjusted to eliminate new sales agreements entered into during the year that contained an expectation of repurchase, which had previously been reported as external sales.
^(ii)	Refer to the section titled Non-IFRS Financial Measures in this news release.

Sales for the second quarter decreased 0.4% to $1,260.9 million, compared to $1,265.8 million last year. Sales in the Prepared Foods operating unit increased approximately 1.0%, with prepared meats increasing 3.2% offset by declines in poultry and plant protein of 3.9% and 2.5% respectively. Sales in the Pork operating unit decreased by 4.2% compared to last year. Favourable mix shift and food service volumes drove the increase in sales in prepared meats, while decreases in fresh poultry volume were driven by reduced sales to industrial channels with repatriation of volume to the London poultry facility partly offset by mix and retail growth. Plant protein sales continued to decline in line with the overall plant protein market. Pork sales declined with lower buy to sell volumes and a negative foreign exchange impact.

Year-to-date sales for 2024 decreased 0.9% to $2,414.1 million compared to $2,436.9 million last year. The decline in sales was driven by factors consistent with those mentioned above and a reduction in hog purchases for processing in the first quarter of 2024.

Gross profit for the second quarter increased to $131.2 million, (gross margin⁽ⁱ⁾ of 10.4%) compared to $93.6 million (gross margin of 7.4%) last year. The improvement in gross profit was driven by improving pork market conditions, reduced start-up expenses in the London Poultry facility and Bacon Centre of Excellence, and improved operational efficiencies across the network, all of which were partially offset by unrealized mark to market valuation adjustment on biological assets due to changes in hog and feed markets.

Year-to-date gross profit for 2024 was $357.5 million (gross margin of 14.8%) compared to $170.0 million (gross margin of 7.0%) last year. Gross profit improvement was driven by improving pork market conditions, reduced start-up expenses in the London poultry facility and Bacon Centre of Excellence, operational efficiencies, and unrealized gains on mark to market of biological assets driven by changes in hog and feed markets.

SG&A expenses for the second quarter were $116.6 million, compared to $106.2 million last year. The increase in SG&A expenses was primarily driven by higher variable compensation and higher consulting fees.

Year-to-date SG&A expenses for 2024 were $226.7 million compared to $208.9 million last year. The increase in SG&A expenses was driven by factors similar to those noted above.

Adjusted Operating Earnings for the second quarter were $78.1 million, compared to $45.9 million last year, driven primarily by the drivers noted above for gross profit and SG&A, and excluding the impacts of unrealized mark to market valuation adjustments and start-up expenses, which are excluded in the calculation of Adjusted Operating Earnings.

Year-to-date Adjusted Operating Earnings for 2024 were $131.1 million compared to $65.2 million last year, consistent with factors noted above.

Adjusted EBITDA for the second quarter were $140.9 million, compared to $103.1 million last year, driven by factors consistent with those noted above and also excluding the impact of unrealized mark to market valuation adjustments and start-up expenses. Adjusted EBITDA Margin for the second quarter of 2024 was 11.2% compared to 8.1% last year, also driven by factors consistent with those noted above.

Year-to-date Adjusted EBITDA for 2024 were $257.3 million compared to $178.4 million last year, driven by factors consistent with those noted above. Year-to-date Adjusted EBITDA Margin for 2024 was 10.7% compared to 7.3% last year, also driven by factors consistent with those noted above.

Adjusted EBT for the second quarter were $34.4 million, compared to $6.7 million last year, driven by factors consistent with those noted above, partially offset by a $6.1 million increase in interest expense as a result of higher interest rates and also excluding the impacts of unrealized mark to market valuation adjustments and start-up expenses.

Year-to-date Adjusted EBT were $44.8 million compared to a loss of $7.3 million last year, driven by factors consistent with those noted above, as well as a $16.6 million increase in interest expense as a result of higher interest rates and higher debt levels.

Other Matters

On August 7, 2024, the Board of Directors approved a quarterly dividend of $0.22 per share, $0.88 per share on an annual basis, payable September 27, 2024 to shareholders of record at the close of business September 6, 2024. Unless indicated otherwise by the Company at or before the time the dividend is paid, the dividend will be considered an eligible dividend for the purposes of the "Enhanced Dividend Tax Credit System". The Board of Directors has also approved the issuance of common shares from treasury at a two percent discount under the Company's Dividend Reinvestment Plan ("DRIP"). Under the DRIP, investors holding the Company's common shares can receive common shares instead of cash dividend payments. Further details, including how to enroll in the program are available at https://www.mapleleaffoods.com/investors/stock-information.com.

Conference Call

A conference call will be held at 9:00 a.m. ET on August 8, 2024, to review Maple Leaf Foods' second quarter financial results. To participate in the call, please dial 289-819-1350 or 1-800-836-8184. For those unable to participate, playback will be made available an hour after the event at 289-819-1450 or 1-888-660-6345 (Passcode: 01201#).

A webcast of the second quarter conference call will also be available at: https://www.mapleleaffoods.com/investors/events-and-presentations/ 

The Company's full unaudited condensed consolidated interim financial statements ("Consolidated Interim Financial Statements") and related Management's Discussion and Analysis are available on the Company's website and on SEDAR+ at www.sedarplus.ca.

An investor presentation related to the Company's second quarter financial results is available at www.mapleleaffoods.com under Presentations and Webcasts on the Investors page.

Outlook

Maple Leaf Foods is a leading consumer protein company built on a powerful portfolio of brands, with a leading voice in sustainability and food security. The Company's strategic Blueprint defines how it will advance its vision to be the Most Sustainable Protein Company on Earth while delivering on its commercial and financial objectives.

The Company recognizes that macro-economic factors and global conflict continue to define the current operating environment, contributing to higher interest rates, inflation, supply chain tensions, and pressures on agricultural, commodity and foreign exchange markets. As a result, consumers and businesses alike are adapting their behaviour which impacts demand and product mix. The Company leverages its data-driven insights to stay close to these dynamics, and it is confident in the resilience of its brands, business model and strategy to manage through prevailing economic conditions.

Earlier this year, Maple Leaf Foods refreshed its Blueprint and announced it was realigning its organizational structure to support its new strategic orientation as it brings together its Meat and Plant Protein businesses under a single umbrella with a clear and consistent focus on driving profitable growth in Canada, the U.S., and internationally across its entire protein portfolio.

With this focus, the Company expects to achieve an overall consolidated Adjusted EBITDA margin target of 14% to 16% in normal market conditions. Prior to this year, this Adjusted EBITDA margin target applied to the previous Meat Protein segment but now applies on a consolidated protein basis.

For the full year 2024, the Company expects:

• Low single-digit revenue growth
• Adjusted EBITDA margin expansion from 2023, supported by the benefits of:
  • Profitable growth of its leading portfolio of protein brands
  • Returns from investments in the London Poultry Plant and the Bacon Centre of Excellence
  • Leadership in sustainable meats
  • Driving operational and cost efficiencies
• To generate increased Free Cash Flow and delever its balance sheet by:
  • Improving margins and overall profitability as outlined above
  • Generating the targeted returns on its capital investments at the London Poultry Plant and the Bacon Centre of Excellence, including reducing start-up expenses, maximizing efficiencies and onboarding new customers
  • Exercising disciplined capital management, with total capital expenditures this year expected to be in the range of $120 - $140 million, largely focused on maintenance capital and optimization of its existing network

Maple Leaf Foods will also continue to advance its ambitious sustainability agenda, including leading the real food movement, advancing its animal care initiatives, seeking solutions to address food insecurity, accelerating its efforts to reduce its environmental footprint and continuing to deliver safe food made in a safe work environment.

On July 9, 2024, Maple Leaf Foods announced plans to separate into two independent public companies through the spin-off of its pork business. The Company expects that this transaction will be completed in 2025.

Non-IFRS Financial Measures

The Company uses the following non-IFRS measures: Adjusted Operating Earnings, Adjusted Earnings per Share, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EBT, Construction Capital, Net Debt, Net Debt to trailing four quarters Adjusted EBITDA, Free Cash Flow and Return on Net Assets. Management believes that these non-IFRS measures provide useful information to investors in measuring the financial performance of the Company for the reasons outlined below. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.

Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT

Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT are non-IFRS measures used by Management to evaluate financial operating results. Adjusted Operating Earnings is defined as earnings before other income, income taxes and interest expense adjusted for items that are not considered representative of ongoing operational activities of the business and certain items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying or related asset is sold or transferred. Adjusted EBITDA is defined as Adjusted Operating Earnings plus depreciation and intangible asset amortization, adjusted for items included in other expense that are considered representative of ongoing operational activities of the business. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by sales. Adjusted EBT is used annually by the Company to evaluate its performance and is a component of calculating bonus entitlements under the Company's short term incentive plan. It is defined as Adjusted EBITDA plus interest income, less depreciation and amortization, and interest expense. 

The table below provides a reconciliation of earnings (loss) before income taxes as reported under IFRS in the Consolidated Interim Financial Statements to Adjusted Operating Earnings, Adjusted EBITDA and Adjusted EBT for the three and six months ended June 30, 2024 as indicated below. Management believes that these non-IFRS measures are useful in assessing the performance of the Company's ongoing operations and its ability to generate cash flows to fund its requirements, including the Company's capital investment program.

	Three months ended June 30,		Six months ended June 30,
($ millions)^(i)(Unaudited)	2024	2023	2024	2023
Earnings (loss) before income taxes	$            (32.5)	$            (63.7)	$               41.3	$         (133.7)
Interest expense and other financing costs	43.6	37.6	85.7	69.2
Other expense (income)	(3.5)	2.6	(2.3)	6.9
Restructuring and other related costs	6.9	11.0	6.2	18.8
Earnings (loss) from operations	$               14.5	$            (12.6)	$             130.8	$           (38.9)
Start-up expenses from Construction Capital^(ii)	4.4	33.8	15.8	68.5
Change in fair value of biological assets	52.5	27.5	(16.7)	28.7
Unrealized and deferred (gain) loss on derivative contracts	6.8	(2.8)	1.1	6.8
Adjusted Operating Earnings	$               78.1	$               45.9	$             131.1	$             65.2
Depreciation and amortization^(v)	63.7	59.7	128.6	117.4
Items included in other income (expense) representative     of ongoing operations^(iii)	(0.9)	(2.5)	(2.4)	(4.1)
Adjusted EBITDA	$             140.9	$             103.1	$             257.3	$           178.4
Adjusted EBITDA Margin^(iv)	11.2 %	8.1 %	10.7 %	7.3 %
Interest expense and other financing costs	(43.6)	(37.6)	(85.7)	(69.2)
Interest income	0.8	0.8	1.8	0.8
Depreciation and amortization	(63.7)	(59.7)	(128.6)	(117.4)
Adjusted EBT	$               34.4	$                  6.7	$               44.8	$             (7.3)

^(i)	Totals may not add due to rounding.
^(ii)	Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads including depreciation and other temporary expenses required to ramp-up production.
^(iii)	Primarily includes certain costs associated with sustainability projects, gains and losses on the impairment and sale of long-term assets, legal settlements, gains and losses on investments, and other miscellaneous expenses.
^(iv)	Quarterly amounts for 2023 have been adjusted to eliminate new sales agreements entered into during the year that contained an expectation of repurchase, which had previously been reported as external sales.
^(v)	Depreciation included in start-up expenses is excluded from this line.

Adjusted Earnings per Share

Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as basic earnings per share and is adjusted on the same basis as Adjusted Operating Earnings. The table below provides a reconciliation of basic earnings per share as reported under IFRS in the Consolidated Interim Financial Statements to Adjusted Earnings per Share for the three and six months ended June 30 as indicated below. Management believes this basis is the most appropriate on which to evaluate financial results as they are representative of the ongoing operations of the Company.

($ per share) (Unaudited)	Three months ended June 30,				Six months ended June 30,
	2024		2023		2024		2023
Basic (loss) earnings per share		$          (0.21)		$          (0.44)		$           0.21		$          (0.92)
Restructuring and other related costs^(i)		0.04		0.08		0.04		0.14
Items included in other expense not considered representative of ongoing operations^(ii)		(0.03)		0.01		(0.02)		0.02
Start-up expenses from Construction Capital^(iii)		0.03		0.21		0.10		0.42
Change in fair value of biological assets		0.31		0.17		(0.12)		0.18
Change in unrealized and deferred fair value on derivatives		0.04		(0.02)		0.01		0.04
Adjusted Earnings per Share		$           0.18		$           0.00		$           0.22		$          (0.12)

^(i)	Includes per share impact of restructuring and other related costs, net of tax.
^(ii)	Primarily includes legal fees and settlements, gains or losses on investment property, and transaction related costs, net of tax.
^(iii)	Start-up expenses are temporary costs as a result of operating new facilities that are or have been classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads and other temporary expenses required to ramp-up production, net of tax.

Construction Capital

Construction Capital, a non-IFRS measure, is used by Management to evaluate the amount of capital resources invested in specific strategic development projects that are not yet operational. It is defined as investments and related financing charges in projects over $50.0 million that are related to longer-term strategic initiatives, with no returns expected for at least 12 months from commencement of construction and the asset is re-categorized from Construction Capital once operational.  

Construction Capital balance was nil as at December 31, 2023, and there was no activity during 2024. The Construction Capital activity for the six months ended June 30, 2023 is shown in the table below.

($ thousands) (Unaudited)		2023
Property and equipment and intangibles at January 1		$           2,663,985
Other capital and intangible assets at January 1^(i)		2,654,419
Construction Capital at January 1		$                  9,566
Additions		8,822
Construction Capital at March 31		$                18,388
Additions		18,896
Construction Capital at June 30^(ii)		$                37,284
Other capital and intangible assets at June 30^(i)		2,598,055
Property and equipment and intangibles at June 30		$           2,635,339
Construction Capital debt financing^(iii)(iv)		$                36,589

^(i)	Other capital and intangible assets consists of property and equipment and intangibles that do not meet the definition of Construction Capital.
^(ii)	As at June 30, 2023 the net book value of Construction Capital includes $0.5 million related to intangible assets.
^(ii)	June 30, 2023 does not include $1,011.3 million in capital that has been transferred out but is still in the start-up stage.
^(iv)	Assumed to be fully funded by debt to the extent that the Company has Net Debt outstanding. Construction Capital debt financing excludes interest paid and capitalized.

Net Debt

The following table reconciles Net Debt and Net Debt to trailing four quarters Adjusted EBITDA to amounts reported under IFRS in the Company's Consolidated Interim Financial Statements as at June 30 as indicated below. The Company calculates Net Debt as cash and cash equivalents, less current and long-term debt and bank indebtedness. Management believes this measure is useful in assessing the amount of financial leverage employed.

($ thousands) (Unaudited)		As at June 30,
		2024		2023
Cash and cash equivalents		$    158,381		$    156,859
Current portion of long-term debt		$   (300,371)		$   (398,394)
Long-term debt		(1,581,093)		(1,565,822)
Total debt		$ (1,881,464)		$(1,964,216)
Net Debt		$(1,723,083)		$(1,807,357)
Adjusted EBITDA for the six months ended		$    257,310		$    178,430
Trailing four quarters Adjusted EBITDA^(i)		$    506,468		$    310,411
Net Debt to trailing four quarters Adjusted EBITDA		3.4		5.8

^(i)	Trailing four quarters includes Q3 2023, Q4 2023, Q1 2024 and Q2 2024 for 2024; and Q3 2022, Q4 2022, Q1 2023 and Q2 2023 for 2023.

Free Cash Flow 

Free Cash Flow, a non-IFRS measure, is used by Management to evaluate cash flow after investing in the maintenance of the Company's asset base. It is defined as cash provided by operations, less Maintenance Capital⁽ⁱ⁾ and associated interest paid and capitalized. The following table calculates Free Cash Flow for the periods indicated below:

($ thousands) (Unaudited)	Three months ended June 30,			Six months ended June 30,
		2024	2023		2024		2023
Cash provided by (used in) operating activities		$     45,496	$     (57,004)		$    132,821		$     (21,290)
Maintenance Capital^(i)		(18,250)	(19,070)		(31,686)		(42,178)
Interest paid and capitalized related to Maintenance     Capital		(220)	(252)		(483)		(486)
Free Cash Flow		$     27,026	$     (76,326)		$    100,652		$     (63,954)

^(i)

Maintenance Capital is defined as non-discretionary investment required to maintain the Company's existing operations and competitive position. For the three and six months ended June 30, 2024, total capital spending of $16.3 million and $40.1 million (2023: $55.9 million and $105.1 million) shown on the Consolidated Statements of Cash Flows is made up of Maintenance Capital of $18.3 million and $31.7 million (2023: $19.1 million and $42.2 million), and Growth Capital was a net cash inflow of $2.0 million for the three months ended June 30, 2024 as a result of government grants received during the second quarter and Growth Capital was a net outflow of $8.4 million for the six months ended June 30, 2024 (2023: $36.8 million and $62.9 million). Growth Capital is defined as discretionary investment meant to create stakeholder value through initiatives that for example, expand margins, increase capacities or create further competitive advantage

Return on Net Assets ("RONA") 

RONA is calculated by dividing tax effected earnings from operations (adjusted for items which are not considered representative of the underlying operations of the business) by average monthly net assets. Net assets are defined as total assets (excluding cash and deferred tax assets) less non-interest bearing liabilities (excluding deferred tax liabilities). Management believes that RONA is an appropriate basis upon which to evaluate long-term financial performance.

Forward-Looking Statements

This document contains, and the Company's oral and written public communications often contain, "forward-looking information" within the meaning of applicable securities law. These statements are based on current expectations, estimates, projections, beliefs, judgements and assumptions based on information available at the time the applicable forward-looking statement was made and in light of the Company's experience combined with its perception of historical trends. Such statements include, but are not limited to, statements with respect to objectives and goals, in addition to statements with respect to beliefs, plans, targets, goals, objectives, expectations, anticipations, estimates, and intentions. Forward-looking statements are typically identified by words such as "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "could", "would", "believe", "plan", "intend", "design", "target", "undertake", "view", "indicate", "maintain", "explore", "entail", "schedule", "objective", "strategy", "likely", "potential", "outlook", "aim", "propose", "goal", and similar expressions suggesting future events or future performance. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The Company believes the expectations reflected in the forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon.

Specific forward-looking information in this document may include, but is not limited to, statements with respect to:

• timing, approvals, expected structure, expected benefits, risks, and tax implications associated with the proposed spin-off of the Pork business announced on July 9, 2024 (the "Spin-Off");
• the anticipated future financial performance of the businesses following the Spin-Off, including post separation business structure and the ability of each company to execute their respective business and sustainability strategies; 
• assumptions about the economic environment, including the implications of inflationary pressures on customer and consumer behaviour, supply chains, global conflicts and competitive dynamics;
• expected future cash flows and the sufficiency thereof, sources of capital at attractive rates, future contractual obligations, future financing options, renewal of credit facilities, compliance with credit facility covenants, and availability of capital to fund growth plans, operating obligations and dividends;
• future performance, including future financial objectives, goals and targets, category growth analysis, expected capital spend and expected SG&A expenditures, global pork market dynamics, Japan export market margin outlook, labour markets, inflationary pressures (including the ability to price for inflation);
• potential for a recurrence of a cybersecurity incident on the Company's systems, business and operations, as well as the ability to mitigate the financial and operational impacts, the success of remediation and recovery efforts, the implications of data breaches, and other ongoing risks associated with cybersecurity;
• the execution of the Company's business strategy, including the development and expected timing of business initiatives, brand expansion and repositioning, plant protein category investment and performance, market access in China and Japan, capital allocation decisions (including investment in share repurchases under the NCIB) and investment in potential growth opportunities and the expected returns associated therewith;
• the impact of international trade conditions and markets on the Company's business, including access to markets, global conflict and other social, economic and political factors that affect trade;
• implications associated with the spread of foreign animal disease (such as African Swine Fever ("ASF")) and other animal diseases such as Avian Influenza;
• competitive conditions and the Company's ability to position itself competitively in the markets in which it competes;
• capital projects, including planning, construction, estimated expenditures, schedules, approvals, expected capacity, in-service dates and anticipated benefits of construction of new facilities and expansions of existing facilities;
• the Company's dividend policy, including future levels and sustainability of cash dividends, the tax treatment thereof and future dividend payment dates;
• the impact of commodity prices and foreign exchange impacts on the Company's operations and financial performance, including the use and effectiveness of hedging instruments;
• operating risks, including the execution, monitoring and continuous improvement of the Company's food safety programs, animal health initiatives, cost reduction initiatives, and service levels (including service level penalties);
• the implementation, cost and impact of environmental sustainability initiatives, the ability of the Company to achieve its sustainability objectives, changing climate and sustainability laws and regulation, changes in customer and consumer expectations related to sustainability matters, as well as the anticipated future cost of remediating environmental liabilities;
• the adoption of new accounting standards and the impact of such adoption on the financial position of the Company;
• expectations regarding pension plan performance, including future pension plan assets, liabilities and contributions; and
• developments and implications of actual or potential legal actions.

Various factors or assumptions are typically applied by the Company in drawing conclusions or making the forecasts, projections, predictions or estimations set out in the forward-looking statements. These factors and assumptions are based on information currently available to the Company, including information obtained by the Company from third-party sources and include but are not limited to the following:

• expectations and assumptions concerning the timing and completion of the proposed spin-off of the Pork business announced on July 9, 2024;
• expectations regarding the adaptations in operations, supply chain, customer and consumer behaviour, economic patterns (including but not limited to global pork markets), foreign exchange rates, international trade dynamics and access to capital, including possible presence or absence of structural changes associated with the economic recovery since the pandemic and global conflicts;
• the competitive environment, associated market conditions and market share metrics, category growth or contraction, the expected behaviour of competitors and customers and trends in consumer preferences;
• the success of the Company's business strategy and the relationship between pricing, inflation, volume and sales of the Company's products;
• prevailing commodity prices (especially in pork and feed markets), interest rates, tax rates and exchange rates;
• potential impacts related to cybersecurity matters, including security costs, the potential for a future incident, the risks associated with data breaches, the availability of insurance, the effectiveness of remediation and prevention activities, third party activities, ongoing impacts, customer, consumer and supplier responses and regulatory considerations;
• the economic condition of and the sociopolitical dynamics between Canada, the U.S., Japan and China, and the ability of the Company to access markets and source ingredients and other inputs in light of global sociopolitical disruption, and the ongoing impact of global conflicts on inflation, trade and markets;
• the spread of foreign animal disease (including ASF and Avian Influenza), preparedness strategies to manage such spread, and implications for all protein markets;
• the availability of and access to capital to fund future capital requirements and ongoing operations;
• expectations regarding participation in and funding of the Company's pension plans;
• the availability of insurance coverage to manage certain liability exposures;
• the extent of future liabilities and recoveries related to legal claims;
• prevailing regulatory, tax and environmental laws; and
• future operating costs and performance, including the Company's ability to achieve operating efficiencies and maintain sales volumes, turnover of inventories and turnover of accounts receivable.

Readers are cautioned that these assumptions may prove to be incorrect in whole or in part. The Company's actual results may differ materially from those anticipated in any forward-looking statements.

Factors that could cause actual results or outcomes to differ materially from the results expressed, implied, or projected in the forward-looking statements contained in this document include, among other things, risks associated with the following:

• the spin-off of the Pork business not proceeding as expected (within the expected timeline or at all), including as a result of the conditions of the transaction not being satisfied,
• the spin-off of the Pork business not delivering the intended benefits, including the ability of the separated companies to each succeed as a standalone publicly trading company;
• unanticipated effects of the announcement and potential spin-off on the market price for the Company's securities or the financial performance of the Company;
• the results of each of the separated companies' execution of their respective business plans, the degree to which benefits are realized or not and the timing to realize those benefits, including the implications on the financial results of each; 
• presence or absence of adaptations or structural changes arising since the economic recovery following the pandemic which may have implications for the operations and financial performance of the Company, as well the ongoing implications for macro socio-economic trends and global conflict;
• macro economic trends, including inflation, consumer behaviour, recessionary indicators, labour availability and labour market dynamics and international trade trends (including global pork markets);
• the results of the Company's execution of its business plans, the degree to which benefits are realized or not, and the timing associated realizing those benefits, including the implications on cash flow;
• competition, market conditions, and the activities of competitors and customers, including the expansion or contraction of key categories, inflationary pressures, pork market dynamics and Japan export margins;
• cybersecurity and maintenance and operation of the Company's information systems, processes and data, recovery, restoration and long term impacts of the cybersecurity event, the risk of future cybersecurity events, actions of third parties, risks of data breaches, effectiveness of business continuity planning and execution, and availability of insurance;
• the health status of livestock, including the impact of potential pandemics;
• international trade and access to markets and supplies, as well as social, political and economic dynamics, including global conflicts;
• operating performance, including manufacturing operating levels, fill rates and penalties;
• availability of and access to capital, and compliance with credit facility covenants;
• decisions respecting the return of capital to shareholders;
• the execution of capital projects and investment maintenance capital;
• food safety, consumer liability and product recalls;
• climate change, climate regulation and the Company's sustainability performance;
• strategic risk management;
• acquisitions and divestitures;
• fluctuations in the debt and equity markets;
• fluctuations in interest rates and currency exchange rates;
• pension assets and liabilities;
• cyclical nature of the cost and supply of hogs and the competitive nature of the pork market generally;
• the effectiveness of commodity and interest rate hedging strategies;
• impact of changes in the market value of the biological assets and hedging instruments;
• the supply management system for poultry in Canada;
• availability of plant protein ingredients;
• intellectual property, including product innovation, product development, brand strategy and trademark protection;
• consolidation of operations and focus on protein;
• the use of contract manufacturers;
• reputation;
• weather;
• compliance with government regulation and adapting to changes in laws;
• actual and threatened legal claims;
• consumer trends and changes in consumer tastes and buying patterns;
• environmental regulation and potential environmental liabilities;
• consolidation in the retail environment;
• employment matters, including complying with employment laws across multiple jurisdictions, the potential for work stoppages due to non-renewal of collective agreements, recruiting and retaining qualified personnel, reliance on key personnel and succession planning;
• pricing of products;
• managing the Company's supply chain;
• changes in International Financial Reporting Standards and other accounting standards that the Company is required to adhere to for regulatory purposes; and
• other factors as set out under the heading "Risk Factors" in the Company's Management Discussion and Analysis for the year ended December 31, 2023.

The Company cautions readers that the foregoing list of factors is not exhaustive.

Readers are further cautioned that some of the forward-looking information, such as statements concerning future capital expenditures, Adjusted EBITDA Margin expansion, and the Company's ability to achieve its financial targets or projections may be considered to be financial outlooks for purposes of applicable securities legislation. These financial outlooks are presented to evaluate potential future earnings and anticipated future uses of cash flows and may not be appropriate for other purposes. Readers should not assume these financial outlooks will be achieved. 

More information about risk factors can be found under the heading "Risk Factors" in the Company's Annual Management's Discussion and Analysis for the year ended December 31, 2023, that is available on SEDAR+ at www.sedarplus.ca. The reader should review such section in detail. Additional information concerning the Company, including the Company's Annual Information Form, is available on SEDAR+ at www.sedarplus.ca.

All forward-looking statements included herein speak only as of the date hereof. Unless required by law, the Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements contained herein are expressly qualified by this cautionary statement.

Management's Estimates on the Pork business spin-off, and related Non-IFRS measures

The following table presents management's preliminary estimates of certain financial information regarding the new Pork Company and the business that will be retained after the separation by Maple Leaf Foods. These preliminary estimates have not been audited or reviewed by any third party, have been derived from internal management reporting, and reflect sales, cost and expense allocations, including with respect to corporate expenses, as well as other estimates and adjustments, each of which is preliminary in nature and subject to change. 

Management believes that these preliminary estimates are useful in providing an indication of the relative size of the businesses upon separation. Each of these figures is expected to be refined prior to the separation, with full financial details to be presented in the prospectus and management information circular to be filed in connection with the transaction.

Last twelve months ended June 30, 2024

(in millions of Canadian dollars) (unaudited)

New Pork Company

Maple Leaf Foods^(i)

Eliminations

Consolidated Maple Leaf Foods Inc.

Sales

$        1,661

^(ii)

$        3,562

^(iii)

$          (378)

^(iv)

$                            4,845

^(v)

Adjusted EBITDA

110

^(vi)

396

^(vii)

—

506

^(v),(viii)

Adjusted EBITDA Margin^(ix)

6.6 %

11.1 %

— %

10.5 %

Estimate of potential impact of    separation^*

~$2 - (2)

~$(3) - (7)

Pro Forma Adjusted EBITDA^(xi)

~110

~390

Pro Forma Adjusted EBITDA margin^(xii)

~7%

~11%

Estimate of potential market     normalization impact^(xiii)

~80-85

Pro Forma normalized Adjusted EBITDA^(xiv)

~190

Pro Forma normalized Adjusted     EBITDA Margin^(xv)

~11%

Note:
i.	Refers to the business that will be retained after the separation by Maple Leaf Foods Inc.
ii.	Represents management's preliminary estimate of sales (both to Maple Leaf Foods and to external third parties) attributable to the business that will be transferred to the new Pork Company in the separation for the period presented.
iii.	Represents management's preliminary estimate of sales attributable to the business that will be retained by Maple Leaf Foods after the separation for the period presented.
iv.	Primarily represents management's preliminary estimate of sales from the new Pork Company to Maple Leaf Foods for the period presented.
v.	Calculated by adding the previously reported results for the year ended December 31, 2023 to results for the six months ended June 30, 2024 and subtracting results for the six months ended June 30, 2023.  These results are reported in the Company's MD&A filed on SEDAR and SEDAR+ for the year ended December 31, 2023, the quarter ended June 30, 2024 and the quarter ended June 30, 2023.
vi.	Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to the new Pork Company for the period presented. As noted above, this estimate is subject to change and is expected to be refined prior to the separation.
vii.	Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Maple Leaf Foods (as defined in note (i) above) for the period presented. As noted above, this estimate is subject to change and is expected to be refined prior to the separation.
viii.	For a definition of Adjusted EBITDA (consolidated), and a reconciliation of Adjusted EBITDA (consolidated) for the periods described in note (iv) above to consolidated net income for such periods, see the Company's MD&A filed on SEDAR and SEDAR+ for the year ended December 31, 2023, the quarter ended June 30, 2024 and the quarter ended June 30, 2023.
ix.	Defined as Adjusted EBITDA divided by Sales. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above.
x.	Represents management's preliminary estimate of the potential impact on Adjusted EBITDA of the new Pork Company and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on July 1, 2023. Primarily relates to management's preliminary estimate of (1) a change in Adjusted EBITDA of the new Pork Company and an offsetting change in Adjusted EBITDA of Maple Leaf Foods as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation, (2) public company costs that would have been incurred by the new Pork Company, and (3) a reallocation of certain SG&A expenses from the new Pork Company to Maple Leaf Foods. As noted above, this estimate is subject to change and is expected to be refined prior to the separation.
xi	Defined as Adjusted EBITDA plus management's preliminary estimate of the potential impact of the separation described in, and subject to the qualifications described in, note (10) above.
xii.	Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above divided by Sales. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above.
xiii.	Presented for illustrative purposes only, based on management estimates and assumptions, to indicate what the potential impact on Pro Forma Adjusted EBITDA may have been if market conditions during the period presented had reflected normal market conditions, defined as the 5-year pre-pandemic (2015 – 2019) average ("Normal Market Conditions"). Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period.
xiv.	Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above, plus management's preliminary estimate of the potential impact if market conditions during the period presented had reflected Normal Market Conditions, subject to the qualifications described in note (xiii) above. This metric is presented for illustrative purposes only and is not intended to be indicative of potential financial results for any future period.
xv.	Defined as Pro Forma normalized Adjusted EBITDA, as described in note (xiv) above, divided by Sales.  This metric is presented for illustrative purposes only and is based on management estimates and assumptions. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA Margin would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period.

Adjusted EBITDA, Pro Forma Adjusted EBITDA, and Pro Forma normalized Adjusted EBITDA, and related margins, as presented in the table above, are non-IFRS metrics and do not have a standardized meaning prescribed by IFRS.  Consequently, they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.

About Maple Leaf Foods Inc.

Maple Leaf Foods is a leading protein company responsibly producing food products under leading brands including Maple Leaf^®, Maple Leaf Prime^®, Maple Leaf Natural Selections^®, Schneiders^®, Schneiders^® Country Naturals^®, Mina^®, Greenfield Natural Meat Co.^®, Lightlife^® and Field Roast™. The Company employs approximately 13,500 people and does business primarily in Canada, the U.S. and Asia. The Company is headquartered in Mississauga, Ontario and its shares trade on the Toronto Stock Exchange (MFI).

Consolidated Interim Balance Sheets

(In thousands of Canadian dollars) (Unaudited)	As at June 30, 2024		As at June 30, 2023		As at December 31,  2023
ASSETS
Cash and cash equivalents		$         158,381		$    156,859		$         203,363
Accounts receivable		184,300		205,930		183,798
Notes receivable		44,886		48,159		33,220
Inventories		580,472		523,377		542,392
Biological assets		124,688		111,796		114,917
Income taxes recoverable		62,761		69,521		88,896
Prepaid expenses and other assets		35,203		36,786		44,865
Assets held for sale		27,438		11,204		—
Total current assets		$     1,218,129		$ 1,163,632		$     1,211,451
Property and equipment		2,186,520		2,285,314		2,251,710
Right-of-use assets		171,692		150,211		154,610
Investments		16,112		22,869		15,749
Investment property		34,744		5,289		57,144
Employee benefits		116,800		49,699		26,785
Other long-term assets		22,271		9,601		22,336
Deferred tax asset		42,504		41,450		40,854
Goodwill		477,353		477,353		477,353
Intangible assets		343,457		350,025		345,129
Total long-term assets		$     3,411,453		$ 3,391,811		$     3,391,670
Total assets		$     4,629,582		$ 4,555,443		$     4,603,121
LIABILITIES AND EQUITY
Accounts payable and accruals		$        543,792		$    528,481		$        548,444
Current portion of provisions		9,673		23,837		9,846
Current portion of long-term debt		300,371		398,394		400,735
Current portion of lease obligations		40,544		37,749		38,031
Income taxes payable		2,351		1,600		2,382
Other current liabilities		24,986		17,998		32,974
Total current liabilities		$         921,717		$ 1,008,059		$     1,032,412
Long-term debt		1,581,093		1,565,822		1,550,080
Lease obligations		157,550		137,029		142,286
Employee benefits		60,796		64,251		64,196
Provisions		1,998		2,281		2,041
Other long-term liabilities		1,167		928		1,124
Deferred tax liability		330,232		223,190		296,203
Total long-term liabilities		$     2,132,836		$ 1,993,501		$     2,055,930
Total liabilities		$     3,054,553		$ 3,001,560		$     3,088,342
Shareholders' equity
Share capital		$        886,876		$    859,046		$        873,477
Retained earnings		640,589		671,870		597,429
Contributed surplus		6,773		—		3,227
Accumulated other comprehensive income		44,222		30,150		47,829
Treasury shares		(3,431)		(7,183)		(7,183)
Total shareholders' equity		$     1,575,029		$ 1,553,883		$     1,514,779
Total liabilities and equity		$     4,629,582		$ 4,555,443		$     4,603,121

Consolidated Interim Statements of (Loss) Earnings

(In thousands of Canadian dollars, except share amounts) (Unaudited)	Three months ended June 30,				Six months ended June 30,
		2024		2023^(i)		2024		2023^(i)
Sales		$ 1,260,878		$ 1,265,841		$ 2,414,103		$ 2,436,908
Cost of goods sold		1,129,723		1,172,245		2,056,608		2,266,865
Gross profit		$    131,155		$      93,595		$    357,495		$    170,042
Selling, general and administrative expenses		116,649		106,184		226,682		208,897
Earnings (loss) before the following:		$      14,506		$     (12,589)		$    130,813		$     (38,855)
Restructuring and other related costs		6,893		11,026		6,168		18,775
Other (income) expense		(3,492)		2,579		(2,335)		6,874
Earnings (loss) before interest and income taxes		$       11,105		$     (26,194)		$    126,980		$     (64,504)
Interest expense and other financing costs		43,637		37,554		85,720		69,157
(Loss) earnings before income taxes		$     (32,532)		$     (63,748)		$      41,260		$   (133,661)
Income tax (recovery) expense		(6,359)		(10,070)		15,882		(22,279)
(Loss) earnings		$     (26,173)		$     (53,678)		$      25,378		$   (111,382)
Earnings (loss) per share attributable to common     shareholders:
Basic (loss) earnings per share		$         (0.21)		$         (0.44)		$          0.21		$         (0.92)
Diluted (loss) earnings per share		$         (0.21)		$         (0.44)		$          0.20		$         (0.92)
Weighted average number of shares (millions):
Basic		122.9		121.5		122.7		121.5
Diluted		122.9		121.5		123.8		121.5

^(i)	Quarterly amounts for 2023 have been adjusted see Note 17 in the condensed consolidated interim financial statements.

Consolidated Interim Statements of Other Comprehensive Income (Loss)

(In thousands of Canadian dollars) (Unaudited)	Three months ended June 30,				Six months ended June 30,
		2024		2023		2024		2023
(Loss) earnings		$  (26,173)		$   (53,678)		$   25,378		$(111,382)
Other comprehensive income
Actuarial gains (losses) that will not be reclassified to profit or loss (Net of tax of $22.5 million and $24.7 million; 2023: $8.9 million and $9.6 million)		$   65,346		$     25,779		$   71,951		$   27,903
Change in revaluation surplus (2023: Net of tax of $0.0 million and $1.7 million)		—		—		—		6,993
Total items that will not be reclassified to profit or loss		$   65,346		$     25,779		$   71,951		$   34,896
Items that are or may be reclassified subsequently to profit or loss:
Change in accumulated foreign currency translation adjustment (Net of tax of $0.0 million and $0.0 million; 2023: $0.0 million and $0.0 million)		3,401		(8,686)		11,111		(9,119)
Change in foreign exchange on long-term debt designated as a net investment hedge (Net of tax of $0.6 million and $1.8 million; 2023: $1.2 million and $1.2 million)		(3,226)		6,498		(9,838)		6,618
Change in cash flow hedges (Net of tax of $0.5 million and $0.7 million; 2023: $0.8 million and $1.8 million)		(1,258)		(782)		(4,880)		(3,889)
Total items that are or may be reclassified subsequently to profit or loss		$    (1,083)		$    (2,970)		$    (3,607)		$   (6,390)
Total other comprehensive income		$   64,263		$    22,809		$   68,344		$  28,506
Comprehensive income (loss)		$   38,090		$   (30,869)		$   93,722		$ (82,876)

Consolidated Interim Statements of Changes in Total Equity

				Accumulated other comprehensive income (loss)
(In thousands of Canadian dollars)	Share capital	Retained earnings	Contributed surplus	Foreign currency translation adjustment^(i)	Unrealized gains and losses on cash flow hedges^(i)	Unrealized gains on fair value of investments^(i)	Revaluation surplus	Treasury stock	Total equity
Balance at December 31, 2023	$873,477	597,429	3,227	8,625	4,416	(2,559)	37,347	(7,183)	$1,514,779
Earnings	—	25,378	—	—	—	—	—	—	25,378
Other comprehensive income (loss)^(ii)	—	71,951	—	1,273	(4,880)	—	—	—	68,344
Dividends declared ($0.44 per share)	10,901	(54,169)	—	—	—	—	—	—	(43,268)
Share-based compensation expense	—	—	11,387	—	—	—	—	—	11,387
Deferred taxes on share-based compensation	—	—	(425)	—	—	—	—	—	(425)
Exercise of stock options	2,498	—	—	—	—	—	—	—	2,498
Settlement of share-based compensation	—	—	(7,416)	—	—	—	—	3,752	(3,664)
Balance at June 30, 2024	$886,876	640,589	6,773	9,898	(464)	(2,559)	37,347	(3,431)	$1,575,029
				Accumulated other comprehensive income (loss)
(In thousands of Canadian dollars)	Share capital	Retained earnings	Contributed surplus	Foreign currency translation adjustment	Unrealized gains and losses on cash flow hedges	Unrealized gains on fair value of investments	Revaluation surplus	Treasury stock	Total equity
Balance at December 31, 2022	$850,086	809,616	—	10,972	12,885	2,945	2,745	(25,916)	$1,663,333
Loss	—	(111,382)	—	—	—	—	—	—	(111,382)
Other comprehensive income (loss)^(ii)	—	27,903	—	(2,501)	(3,889)	—	6,993	—	28,506
Dividends declared ($0.42 per share)	—	(51,252)	—	—	—	—	—	—	(51,252)
Share-based compensation expense	—	—	6,062	—	—	—	—	—	6,062
Deferred taxes on share-based compensation	—	—	1,100	—	—	—	—	—	1,100
Exercise of stock options	4,447	—	(1,363)	—	—	—	—	—	3,084
Shares re-purchased	(4,498)	—	(11,595)	—	—	—	—	—	(16,093)
Shares sold by RSU trust	—	—	—	—	—	—	—	9,841	9,841
Settlement of share-based compensation	—	(3,015)	(15,192)	—	—	—	—	8,892	(9,315)
Change in obligation for repurchase of shares	9,011	—	20,988	—	—	—	—	—	29,999
Balance at June 30, 2023	$859,046	671,870	—	8,471	8,996	2,945	9,738	(7,183)	$1,553,883

^(i)	Items that are or may be subsequently reclassified to profit or loss.
^(ii)	Included in other comprehensive income (loss) is the change in actuarial gains and losses that will not be reclassified to profit or loss and has been reclassified to retained earnings.

Consolidated Interim Statements of Cash Flows

(In thousands of Canadian dollars) (Unaudited)	Three months ended June 30,				Six months ended June 30,
	2024		2023		2024		2023
CASH PROVIDED BY (USED IN):
Operating activities
(Loss) earnings		$     (26,173)		$     (53,678)		$       25,378		$   (111,382)
Add (deduct) items not affecting cash:
Change in fair value of biological assets		52,488		27,547		(16,655)		28,674
Depreciation and amortization		64,446		66,371		130,299		133,796
Share-based compensation		6,089		4,050		11,387		6,062
Deferred income tax (recovery) expense		(8,843)		(5,144)		11,093		(8,018)
Current income tax (recovery) expense		2,484		(4,926)		4,789		(14,261)
Interest expense and other financing costs		43,637		37,554		85,720		69,157
(Gain) loss on sale of long-term assets		(1,326)		741		(1,637)		975
Impairment of property and equipment and ROU assets		118		6,530		118		6,530
Change in fair value of investment property		(5,038)		—		(5,038)		—
Change in fair value of non-designated     derivatives		2,991		(8,635)		(1,674)		(5,526)
Change in net pension obligation		2,169		(136)		3,236		331
Net income taxes refunded (paid)		18,764		3,143		21,746		1,366
Interest paid, net of capitalized interest		(32,459)		(33,838)		(72,936)		(67,628)
Change in provision for restructuring and other     related costs		3,087		(13,545)		(173)		(19,551)
Change in derivatives margin		(1,075)		8,454		1,241		(5,286)
Cash settlement of derivatives		(728)		(2,735)		(2,878)		8,274
Other		2,231		(3,913)		5,324		(3,696)
Change in non-cash operating working capital		(77,366)		(84,844)		(66,519)		(41,107)
Cash provided by (used in) operating activities		$       45,496		$     (57,004)		$     132,821		$     (21,290)
Investing activities
Additions to long-term assets		$     (16,318)		$     (55,869)		$     (40,131)		$   (105,121)
Interest paid and capitalized		(219)		(757)		(574)		(1,238)
Proceeds from sale of long-term assets		2,631		206		3,496		270
Purchase of investments		—		(100)		—		(100)
Cash used in investing activities		$     (13,906)		$     (56,520)		$     (37,209)		$   (106,189)
Financing activities
Dividends paid		$     (21,607)		$     (25,693)		$     (43,268)		$     (51,252)
Net (decrease) increase in long-term debt		(50,480)		219,554		(81,365)		268,354
Payment of lease obligation		(7,891)		(7,462)		(16,337)		(17,380)
Exercise of stock options		2,498		2,315		2,498		3,084
Repurchase of shares		—		(5,324)		—		(16,093)
Sale (purchase) of treasury shares		—		9,841		—		9,841
Payment of financing fees		(2,122)		(2,281)		(2,122)		(3,292)
Cash (used in) provided by financing activities		$     (79,602)		$     190,950		$   (140,594)		$     193,262
(Decrease) increase in cash and cash equivalents		$     (48,012)		$       77,426		$     (44,982)		$       65,783
Cash and cash equivalents, beginning of period		206,393		79,433		203,363		91,076
Cash and cash equivalents, end of period		$     158,381		$     156,859		$     158,381		$     156,859

SOURCE Maple Leaf Foods Inc.